Krishnaiah, Ch <br/><br/>
Development of a stability-indicating UPLC method for determining olanzapine and its associated degradation products present in active pharmaceutical ingredients and pharmaceutical dosage forms.  [electronic resource] 

 -  Journal of pharmaceutical and biomedical analysis  Mar 2011 
 - 667-73 p.  digital 
<br/><br/> Publication Type: Journal Article; Validation Study 
<br/><br/><label>ISSN: </label>1873-264X 
<br/><br/><label>Standard No.: </label>10.1016/j.jpba.2010.10.013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antipsychotic Agents--analysis<br/>Benzodiazepines--analysis<br/>Chromatography, High Pressure Liquid<br/>Drug Contamination--prevention & control<br/>Drug Stability<br/>Hot Temperature--adverse effects<br/>Hydrogen-Ion Concentration<br/>Limit of Detection<br/>Olanzapine<br/>Oxidation-Reduction<br/>Quality Control<br/>Reproducibility of Results<br/>Spectrometry, Mass, Electrospray Ionization<br/>Tandem Mass Spectrometry<br/>Technology, Pharmaceutical<br/>Time Factors<br/>Ultraviolet Rays--adverse effects